Bempedoic acid

NILEMDO 180 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

180 mg comprimido recubierto con películaSpainMarketedAuthorised 26 Dec 2020

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

NilemdoEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Bempedoic acid

NILEMDO 180 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

180 mg comprimido recubierto con películaSpainMarketedAuthorised 26 Dec 2020

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

NilemdoEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Nilemdo 180 mg, filmomhulde tablettenNetherlands · Filmomhulde tablet · Daiichi Sankyo Europe GmbH

NexletolUnited States · 180MG · tablet · Esperion Theraps INC

Packs

Pack	Code	Status
NILEMDO 180 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 100 comprimidos	607389
NILEMDO 180 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos	729840

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Bempedoic acid
Strength: 180 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 26 Dec 2020
Registration: 1201425002
Marketing authorisation holder: Daiichi Sankyo Europe Gmbh
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica
EU number: EU/1/20/1425